@article{fdi:010076467,
  title = {{M}aternal and infant bone mineral density 1 year after delivery in a randomized, controlled trial of maternal {T}enofovir {D}isoproxil {F}umarate to prevent mother-to-child transmission of hepatitis {B} virus},
  author = {{S}alvadori, {N}icolas and {F}an, {B}. and {T}eeyasoontranon, {W}. and {N}go-{G}iang-{H}uong, {N}icole and {C}ressey, {T}im and {D}ecker, {L}uc and {J}ourdain, {G}onzague and et al.},
  editor = {},
  language = {{ENG}},
  abstract = {{I}n a randomized, double-blind, placebo-controlled trial of tenofovir disoproxil fumarate ({TDF}) use from 28 weeks gestational age to 2 months postpartum to prevent mother-to-child transmission of hepatitis {B} virus, there was no significant effect of maternal {TDF} use on maternal or infant bone mineral density 1 year after delivery/birth.},
  keywords = {{THAILANDE}},
  booktitle = {},
  journal = {{C}linical {I}nfectious {D}iseases},
  volume = {69},
  numero = {1},
  pages = {144--146},
  ISSN = {1058-4838},
  year = {2019},
  DOI = {10.1093/cid/ciy982},
  URL = {https://www.documentation.ird.fr/hor/fdi:010076467},
}